Nipro’s vascular team from Japan, South East Asia, and India landed in Singapore for AsiaPCR 2023 – one of the biggest stages for the vascular sector.

This World Patient Safety Day, Nipro wishes to shed light on the protection of both patients and healthcare professionals.

The first shipment of the Makoto Intravascular Imaging System is on its way to Australia.

We are pleased to announce the unveiling of Nipro Sales Thailand’s new Khon Kaen office.

An Giang Hospital installed Nipro’s Phoenix One DS – a single-stage reverse osmosis (RO) system.

On 15th & 16th April 2023, Nipro is participating at the Asia Primary Angioplasty Congress.

Join us at WCN 2023 from 30th March – 2nd April 2023 in Bangkok, Thailand.

Join us at SingLive 2023 on the 12th January for a special symposium and live case.

Nipro Asia has established a medical device sales subsidiary, Nipro Medical Philippines Corporation.

On November 4th 2022, a one-day continuous medical education (CME) for dialysis staffs was held in Kathmandu, Nepal.

Virtual Presentation: Elastomeric pump – Bringing homecare to the next level on 19 October 2022, 3.00PM

Virtual Presentation with CME Points on 11 October 2022, 2.00PM to 3.00PM

A conference titled, “International CME on Kidney Disease and Hemodialysis” was held in Dhaka on Monday, 29 August, 2022.

Virtual Presentation on 17 August 2022, 1.00PM to 1.30PM

Please join us for an informative evening on Nipro’s latest innovation, CLFine™. Register for webinar or live event here.

On May 31st 2022, an event to celebrate the 12th anniversary of NIPRO’s joint venture in Bangladesh was held, with the presence of the ministers of Bangladesh, the ambassador of Japan, the chairman of medical practitioners and NIPRO managements. 

Nipro is very successful at identifying a problem and providing the solutions both in Japan and internationally. How has this success been achieved, and how does Nipro encourage employees?

“My hope is to have Nipro’s culture which is Willingness to take root firmly. I would like to see my employees have their own plans and to approach every activity with Willingness.” – Mr. Sano

Nipro Corporation unveiled the company’s innovative disposable syringes, a timely solution that can stretch the Covid-19 vaccine dosage.

Virtual Presentation on 27 July 2022, 2.00PM to 2.45PM

Virtual Presentation on 29 June 2022, 1.00PM to 1.30PM

Virtual Presentation with CME Points on 7 June 2022, 1.00PM to 2.30PM

Nipro Corporation has decided to build an integrated production plant for cellulose triacetate (CTA) dialyzers (artificial kidneys) jointly with Toyobo Co., Ltd.

Nipro Corporation won the Disinfection Product Innovation of the Year at the Healthcare Asia Medtech Awards.

We are pleased to announce that our consolidated subsidiary, Nipro Asia Pte Ltd. has established a medical device sales subsidiary, Nipro Sales Vietnam Limited.

Earth, the only living planet with her key inhabitant, chiefy the homo sapiens, are constantly in threat of depletion of her finite resources.

OSAKA — Japanese medical device manufacturer Nipro has decided to spend more than 100 billion yen ($958 million)

Nipro PharmaPackaging acknowledged a long time ago that business growth could only happen hand in hand with challenging sustainability goals.

Nipro Digital Technologies Europe (NDTE) was awarded with 2 certificates: ISO 27001 and ISO 27701.

On Monday 26 February 2022, WCN ’22 Virtual Symposium discusses Nipro’s new product, the Elisio HX.

Nipro is committed to positive patient outcomes and improved quality of life – for people and patients.

2021 is the year that India remembers and celebrates its 75th anniversary of being independent.

Due to the current Covid pandemic, Nipro Malaysia has led a public spirited initiative in collaboration with DaVita.

Welcome back to iMEP! We are happy to share our new training content with you. Are you ready to make the last 4 months of 2021…